Clexio Biosciences is a CNS-first clinical stage company. We are dedicated to developing novel therapies for patients suffering from neurological and psychiatric conditions.
Learn MoreWe identify points of convergence between patients' needs, validated mechanisms of action and technology, to generate new solutions that can be integrated into patients’ lives.
More InfoWe are a multi-asset company with a rich and growing pipeline, from preclinical to Phase 2 development stages. We invent new therapeutic modalities, and bring them quickly from an idea to Proof of Concept and then to full clinical development.
Started in 2018 with strong financial backing and a broad network of partners worldwide
Technological and therapeutic ingenuity to address patients'
unmet needs
Broad experience in Pharma & Biotech, from early innovation to clinical development & regulatory approvals
